Gregory M. Glenn

2011

In 2011, Gregory M. Glenn earned a total compensation of $543.1K as SVP & Chief Medical Officer at Novavax, a 40% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$98,919
Option Awards$87,706
Salary$353,281
Other$3,172
Total$543,078

Glenn received $353.3K in salary, accounting for 65% of the total pay in 2011.

Glenn also received $98.9K in non-equity incentive plan, $87.7K in option awards and $3.2K in other compensation.

Rankings

In 2011, Gregory M. Glenn's compensation ranked 7,775th out of 10,747 executives tracked by ExecPay. In other words, Glenn earned more than 27.7% of executives.

ClassificationRankingPercentile
All
7,775
out of 10,747
28th
Division
Manufacturing
2,847
out of 3,960
28th
Major group
Chemicals And Allied Products
706
out of 1,033
32nd
Industry group
Drugs
499
out of 781
36th
Industry
Biological Products, Except Diagnostic Substances
83
out of 157
47th
Source: SEC filing on April 30, 2012.

Glenn's colleagues

We found six more compensation records of executives who worked with Gregory M. Glenn at Novavax in 2011.

2011

Stanley Erck

Novavax

Chief Executive Officer

2011

Rahul ScD

Novavax

Chief Executive Officer

2011

Frederick Driscoll

Novavax

Chief Financial Officer

2011

Russell Wilson

Novavax

SVP, Business Development

2011

John Trizzino

Novavax

Former SVP, Business Development

2011

Timothy Hahn

Novavax

SVP, Manufacturing and Process Development

News

You may also like